Summary by Moomoo AI
On March 7, 2024, John Trizzino, EVP, CCO, and CBO of Novavax Inc, completed a stock transaction involving the company's common stock. Trizzino exercised options to acquire 28,890 shares of Novavax common stock. On the same day, he sold 13,955 shares at a price of $5.61 per share, resulting in a total market value of $78,287.55 for the disposed shares. Following these transactions, Trizzino's direct holdings in Novavax amounted to 25,590 shares.